Analysed Protara Therapeutics Inc (TARA:NASDAQ) News Sources
Protara Therapeutics Highlights Phase 2 TARA-002 Data in NMIBC, Cites Strong Response Rates at ASCO GU
Yahoo Finance
Protara Therapeutics: TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
FinanzNachrichten.de
TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
MarketWatch
Protara reports encouraging phase 2 results for TARA-002 in bladder cancer study
InvestorsHub on MSN
What is the current price of Protara Therapeutics Inc (TARA:NASDAQ)?
The current price of Protara Therapeutics Inc (TARA:NASDAQ) is $5.77.
Protara Therapeutics Inc (TARA:NASDAQ) absolute price change since previous trading day?
The absolute price change of Protara Therapeutics Inc (TARA:NASDAQ) since the previous trading day is $-0.19.
Protara Therapeutics Inc (TARA:NASDAQ) percentage price change since previous trading day?
The percentage price change of Protara Therapeutics Inc (TARA:NASDAQ) since the previous trading day is -3.19%.
What is This Week's average sentiment score for Protara Therapeutics Inc (TARA:NASDAQ)?
This Week's average sentiment score for Protara Therapeutics Inc (TARA:NASDAQ) is 73 out of 100.
What is This Week's average sentiment for Protara Therapeutics Inc (TARA:NASDAQ)?
This Week's sentiment for Protara Therapeutics Inc (TARA:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.